Europe Intragastric Balloon Market Industry Trends and Forecast to 2034: Segmented by (Type, Filling, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Europe · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$54.7 MnPlaceholder estimate
Estimate 2025$60.0 Mn19.5% of the global market
Projected 2034$139.3 Mn 132%Adds $79.2 Mn over 9 forecast years
CAGR 2025–20349.8%Faster than 70% of 186 Medical Devices markets here
Key players5Companies profiled
Europe is 19.49% of the global market.
Among regions, the largest is North America at $145.1 Mn.
6 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Europe Intragastric Balloon Market Analysis Executive Summary
Intragastric balloons are soft balloons placed in the stomach for a few months to help people eat less and lose weight without surgery.
Key segments of the intragastric Balloon market include type (Single Balloon, Dual Balloon and Swallowable Balloon) and filling (Saline-Filled and Gas-Filled).
Europe Intragastric Balloon market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Europe Intragastric Balloon Market Dynamics
Market Growth Drivers
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the intragastric Balloon market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.
Opportunity
Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the intragastric Balloon market, especially in fast-growing emerging economies.
Market Restraints
High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the intragastric Balloon market. Long-term safety data and lifestyle support are still needed for many patients.
Competitive Landscape for Intragastric Balloon Market in Europe
The intragastric Balloon market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for Intragastric Balloon Market in Europe
Intragastric Balloon in Europe: rules, payment and research
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.[1] In the countries we cover here, medical devices are regulated by ANSM (France)[2], BfArM (Germany)[3], Ministry of Health (Italy)[4], Roszdravnadzor (Russia)[5], AEMPS (Spain)[6], MHRA (UK)[7], IGJ (Netherlands)[8], FAMHP (Belgium)[9], Swissmedic (Switzerland)[10], Läkemedelsverket (Sweden)[11], Danish Medicines Agency (Denmark)[12], URPL (Poland)[13] and TITCK (Turkey)[14]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[15] ClinicalTrials.gov lists 6 studies on Intragastric Balloon that are recruiting, active or about to start in Europe.[16]
[16]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how intragastric Balloon products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Type
4.2 By Filling
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Allurion Technologies
7.2 Apollo Endosurgery
7.3 Spatz Medical
7.4 Obalon Therapeutics
7.5 Helioscopie
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The intragastric Balloon market can be segmented based on various criteria, including type, filling and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in Intragastric Balloon right now, from free public sources.
Clinical trials
6 active trials in UK, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Denmark, Poland, Turkey and Russia
Recruiting, about to start, or running now. Counted across the 13 countries we report on in Europe.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
WHO Global Health Observatory.
Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
How big is the Intragastric Balloon market in Europe?
Placeholder estimate: about $60.0 Mn in 2025, rising to about $139.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Intragastric Balloon market in Europe growing?
Placeholder estimate: about 9.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Intragastric Balloon market report cover?
The report splits the market by type (Single Balloon, Dual Balloon, Swallowable Balloon), filling (Saline-Filled, Gas-Filled) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Intragastric Balloon market?
Key players include Allurion Technologies, Apollo Endosurgery, Spatz Medical, Obalon Therapeutics and Helioscopie.
What is driving the Intragastric Balloon market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the intragastric Balloon market.
Who regulates Intragastric Balloon in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Intragastric Balloon are running in Europe?
6 studies are recruiting, active or about to start in Europe, counted across the 13 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Intragastric Balloon?
PubMed lists 302 papers on Intragastric Balloon added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.